We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
AptarGroup (ATR) Earnings Trump Estimates in Q2, Up Y/Y
Read MoreHide Full Article
AptarGroup, Inc. (ATR - Free Report) delivered second-quarter 2019 adjusted earnings per share of $1.15, beating the Zacks Consensus Estimate of $1.13 by a margin of 1.8%. Further, the bottom line went up 9.5% year over year.
On a reported basis, the company recorded earnings of $1.12 per share compared with the year-ago quarter’s 86 cents.
Total revenues improved 4.5% year over year to $743 million in the second quarter. Core sales growth was 4%, acquisitions contributed 6%, while unfavorable exchange rates unfavorably impacted sales by 5%. Strong broad-based demand for drug delivery and food dispensing solutions drove top-line core growth during the quarter. The top line, however, missed the Zacks Consensus Estimate of $752 million.
Operational Update
Cost of sales inched up 1% to $469 million from $464 million recorded in the year-ago quarter. Gross profit increased 11.4% year over year to $274 million. Gross margin came in at 36.8% during the June-end quarter, up from the prior-year quarter’s 34.6%.
Selling, research, development and administrative expenses rose 6.5% year over year to $114 million. Adjusted operating income went up 9.4% year over year to $105 million. The company reported operating margin of 14.1% compared with the prior year’s 13.5%. Adjusted EBITDA increased 14.2% year over year to $161 million in the April-June quarter.
AptarGroup, Inc. Price, Consensus and EPS Surprise
Total revenues in the Beauty + Homes segment declined 7% year over year to $342 million. Adjusted operating income in the June-end quarter was up 8.7% year over year to $28 million.
Total revenues in the Pharma segment increased 17% year over year to $282 million. Adjusted operating income climbed 14.4% year over year to $85.6 million in the second quarter.
Total revenues in the Food + Beverage segment climbed 17.6% year over year to $118.6 million. Operating income grew 6% year over year to $12.3 million.
Financial Performance
AptarGroup reported cash and cash equivalents of $303 million at the end of the reported quarter, up from $262 million as of Dec 31, 2018. At the quarter’s end, long-term debt was approximately $1,148 million, up from $1,125 million as of Dec 31, 2018.
AptarGroup's board has announced quarterly cash dividend of 36 cents per share. The dividend is payable on Aug 21, to shareholders of record as of Jul 31, 2019.
Outlook
AptarGroup now projects adjusted earnings per share for third-quarter 2019 between 91 cents and 97 cents. It also reflects a higher tax rate of 30-32%. Moreover, the company expects impressive core product sales growth across all segments in the current year. Furthermore, AptarGroup’s Nanopharm and Gateway Analytical acquisitions will likely expand its service portfolio that supports pharmaceutical and biotech customers.
Share Price Performance
Shares of the company have appreciated around 17.8% over the past year, outperforming the industry’s decline of 31.5%.
Zacks Rank & Stocks to Consider
AptarGroup currently carries a Zacks Rank #3 (Hold).
Albany International has an estimated earnings growth rate of 32.3% for 2019. The company’s shares have gained 8% in the past year.
Unifirst has a projected earnings growth rate of 15.17% for the current year. The stock has rallied 2% in a year’s time.
Cintas Corporation has an expected earnings growth rate of 11.15% for the ongoing year. The stock has appreciated 19% over the past year.
This Could Be the Fastest Way to Grow Wealth in 2019
Research indicates one sector is poised to deliver a crop of the best-performing stocks you'll find anywhere in the market. Breaking news in this space frequently creates quick double- and triple-digit profit opportunities.
These companies are changing the world – and owning their stocks could transform your portfolio in 2019 and beyond. Recent trades from this sector have generated +98%, +119% and +164% gains in as little as 1 month.
Image: Bigstock
AptarGroup (ATR) Earnings Trump Estimates in Q2, Up Y/Y
AptarGroup, Inc. (ATR - Free Report) delivered second-quarter 2019 adjusted earnings per share of $1.15, beating the Zacks Consensus Estimate of $1.13 by a margin of 1.8%. Further, the bottom line went up 9.5% year over year.
On a reported basis, the company recorded earnings of $1.12 per share compared with the year-ago quarter’s 86 cents.
Total revenues improved 4.5% year over year to $743 million in the second quarter. Core sales growth was 4%, acquisitions contributed 6%, while unfavorable exchange rates unfavorably impacted sales by 5%. Strong broad-based demand for drug delivery and food dispensing solutions drove top-line core growth during the quarter. The top line, however, missed the Zacks Consensus Estimate of $752 million.
Operational Update
Cost of sales inched up 1% to $469 million from $464 million recorded in the year-ago quarter. Gross profit increased 11.4% year over year to $274 million. Gross margin came in at 36.8% during the June-end quarter, up from the prior-year quarter’s 34.6%.
Selling, research, development and administrative expenses rose 6.5% year over year to $114 million. Adjusted operating income went up 9.4% year over year to $105 million. The company reported operating margin of 14.1% compared with the prior year’s 13.5%. Adjusted EBITDA increased 14.2% year over year to $161 million in the April-June quarter.
AptarGroup, Inc. Price, Consensus and EPS Surprise
AptarGroup, Inc. price-consensus-eps-surprise-chart | AptarGroup, Inc. Quote
Segmental Performance
Total revenues in the Beauty + Homes segment declined 7% year over year to $342 million. Adjusted operating income in the June-end quarter was up 8.7% year over year to $28 million.
Total revenues in the Pharma segment increased 17% year over year to $282 million. Adjusted operating income climbed 14.4% year over year to $85.6 million in the second quarter.
Total revenues in the Food + Beverage segment climbed 17.6% year over year to $118.6 million. Operating income grew 6% year over year to $12.3 million.
Financial Performance
AptarGroup reported cash and cash equivalents of $303 million at the end of the reported quarter, up from $262 million as of Dec 31, 2018. At the quarter’s end, long-term debt was approximately $1,148 million, up from $1,125 million as of Dec 31, 2018.
AptarGroup's board has announced quarterly cash dividend of 36 cents per share. The dividend is payable on Aug 21, to shareholders of record as of Jul 31, 2019.
Outlook
AptarGroup now projects adjusted earnings per share for third-quarter 2019 between 91 cents and 97 cents. It also reflects a higher tax rate of 30-32%. Moreover, the company expects impressive core product sales growth across all segments in the current year. Furthermore, AptarGroup’s Nanopharm and Gateway Analytical acquisitions will likely expand its service portfolio that supports pharmaceutical and biotech customers.
Share Price Performance
Shares of the company have appreciated around 17.8% over the past year, outperforming the industry’s decline of 31.5%.
Zacks Rank & Stocks to Consider
AptarGroup currently carries a Zacks Rank #3 (Hold).
A few better-ranked stocks in the Industrial Products sector are Albany International Corporation (AIN - Free Report) , Unifirst Corporation (UNF - Free Report) , and Cintas Corporation (CTAS - Free Report) . While Albany International and Unifirst flaunt a Zacks Rank #1 (Strong Buy), Cintas carries a Zacks Rank of 2 (Buy), at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
Albany International has an estimated earnings growth rate of 32.3% for 2019. The company’s shares have gained 8% in the past year.
Unifirst has a projected earnings growth rate of 15.17% for the current year. The stock has rallied 2% in a year’s time.
Cintas Corporation has an expected earnings growth rate of 11.15% for the ongoing year. The stock has appreciated 19% over the past year.
This Could Be the Fastest Way to Grow Wealth in 2019
Research indicates one sector is poised to deliver a crop of the best-performing stocks you'll find anywhere in the market. Breaking news in this space frequently creates quick double- and triple-digit profit opportunities.
These companies are changing the world – and owning their stocks could transform your portfolio in 2019 and beyond. Recent trades from this sector have generated +98%, +119% and +164% gains in as little as 1 month.
Click here to see these breakthrough stocks now >>